Vascular endothelial growth factor secretion and immunosuppression are distinct potency mechanisms of human bone marrow mesenchymal stromal cells

被引:1
|
作者
Faircloth, Tyler U. [1 ]
Temple, Sara [1 ]
Parr, Rhett N. [1 ]
Tucker, Anna B. [1 ]
Rajan, Devi [1 ]
Hematti, Peiman [2 ]
Kugathasan, Subra [3 ,4 ]
Chinnadurai, Raghavan [1 ]
机构
[1] Mercer Univ, Sch Med, Dept Biomed Sci, 250 E 66th St, Macon, GA 31404 USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[3] Emory Univ, Sch Med, Div Pediat Gastroenterol, Dept Pediat, Atlanta, GA USA
[4] Childrens Healthcare Atlanta, Atlanta, GA USA
关键词
mesenchymal stromal/stem cells; secretome; angiogenic factors; immunosuppression; human large intestinal endothelial cells; vascular endothelial growth factor A; INFLAMMATORY-BOWEL-DISEASE; OXIDE SYNTHASE INHIBITOR; NITRIC-OXIDE; STEM-CELLS; CROHNS-DISEASE; INTERNATIONAL SOCIETY; ANGIOGENIC PROPERTIES; PERIANAL FISTULAS; INTERFERON-GAMMA; L-NMMA;
D O I
10.1093/stmcls/sxae040
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stromal cells (MSCs) are investigated as cellular therapeutics for inflammatory bowel diseases and associated perianal fistula, although consistent efficacy remains a concern. Determining host factors that modulate MSCs' potency including their secretion of angiogenic and wound-healing factors, immunosuppression, and anti-inflammatory properties are important determinants of their functionality. We investigated the mechanisms that regulate the secretion of angiogenic and wound-healing factors and immune suppression of human bone marrow MSCs. Secretory analysis of MSCs focusing on 18 angiogenic and wound-healing secretory molecules identified the most abundancy of vascular endothelial growth factor A (VEGF-A). MSC viability and secretion of other angiogenic factors are not dependent on VEGF-A secretion which exclude the autocrine role of VEGF-A on MSC's fitness. However, the combination of inflammatory cytokines IFN gamma and TNF alpha reduces MSC's VEGF-A secretion. To identify the effect of intestinal microvasculature on MSCs' potency, coculture analysis was performed between human large intestine microvascular endothelial cells (HLMVECs) and human bone marrow-derived MSCs. HLMVECs do not attenuate MSCs' viability despite blocking their VEGF-A secretion. In addition, HLMVECs neither attenuate MSC's IFN gamma mediated upregulation of immunosuppressive enzyme indoleamine 2,3-dioxygenase nor abrogate suppression of T-cell proliferation despite the attenuation of VEGF-A secretion. We found that HLMVECs express copious amounts of endothelial nitric oxide synthase and mechanistic analysis showed that pharmacological blocking reverses HLMVEC-mediated attenuation of MSC's VEGF-A secretion. Together these results suggest that secretion of VEGF-A and immunosuppression are separable functions of MSCs which are regulated by distinct mechanisms in the host. Graphical Abstract
引用
收藏
页码:736 / 751
页数:16
相关论文
共 50 条
  • [1] Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells
    Kaigler, D
    Krebsbach, PH
    Polverini, PJ
    Mooney, DJ
    TISSUE ENGINEERING, 2003, 9 (01): : 95 - 103
  • [2] Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
    D Gupta
    SP Treon
    Y Shima
    T Hideshima
    K Podar
    YT Tai
    B Lin
    S Lentzsch
    FE Davies
    D Chauhan
    RL Schlossman
    P Richardson
    P Ralph
    L Wu
    F Payvandi
    G Muller
    DI Stirling
    KC Anderson
    Leukemia, 2001, 15 : 1950 - 1961
  • [3] Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
    Gupta, D
    Treon, SP
    Shima, Y
    Hideshima, T
    Podar, K
    Tai, YT
    Lin, B
    Lentzsch, S
    Davies, FE
    Chauhan, D
    Schlossman, RL
    Richardson, P
    Ralph, P
    Wu, L
    Payvandi, F
    Muller, G
    Stirling, DI
    Anderson, KC
    LEUKEMIA, 2001, 15 (12) : 1950 - 1961
  • [4] Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells
    Lipat, Ariel Joy
    Cottle, Chasen
    Pirlot, Bonnie M.
    Mitchell, James
    Pando, Brian
    Helmly, Brian
    Kosko, Joanna
    Rajan, Devi
    Hematti, Peiman
    Chinnadurai, Raghavan
    STEM CELLS TRANSLATIONAL MEDICINE, 2022, 11 (09) : 971 - 986
  • [5] Experimental Study of Human Bone Marrow Mesenchymal Stem Cells Transfected with Vascular Endothelial Growth Factor Gene in Vitro
    Liu, Dewu
    Zhang, Xiangrong
    Guo, Guanghua
    Peng, Yan
    FBIE: 2008 INTERNATIONAL SEMINAR ON FUTURE BIOMEDICAL INFORMATION ENGINEERING, PROCEEDINGS, 2008, : 349 - 352
  • [7] Neuronal differentiation effects of vascular endothelial factor on bone marrow stromal cells
    Yi, Li
    Liu, Qiaoyun
    Han, Jinling
    Ye, Jing
    Zhang, Fangting
    Cui, Guanghui
    Zhou, Zhuqing
    NEURAL REGENERATION RESEARCH, 2010, 5 (09) : 657 - 661
  • [8] The effect of epidermal growth factor on vascular endothelial growth factor secretion by endometrial stromal cells
    Kawano, Y
    Nakamura, S
    Nasu, K
    Narahara, H
    Miyakawa, I
    CLINICAL AND EXPERIMENTAL MEDICINE, 2002, 2 (02) : 69 - 75
  • [9] The effect of epidermal growth factor on vascular endothelial growth factor secretion by endometrial stromal cells
    Y. Kawano
    S. Nakamura
    K. Nasu
    H. Narahara
    I. Miyakawa
    Clinical and Experimental Medicine, 2002, 2 : 69 - 75
  • [10] The Effects of Vascular Endothelial Growth Factor in Differentiation of Bone Marrow Stromal Cell into Endothelial Cell
    Han, Seoung-Yob
    Kim, Jong-Wook
    Jeon, Sang-Yun
    Kim, Heung-Joong
    Kim, Byung-Ock
    Park, Joo-Cheol
    Song, Chang-Hoon
    Jang, Hyun-Seon
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2009, 6 (1-3) : 126 - 130